Zerodha's CEO Nithin Kamath came days after reports of Groww starting to offering regular mutual funds under its new Groww ...

Zerodha's Nithin Kamath and Groww traded sharp posts on X over direct vs regular mutual funds, highlighting competing ...

Zerodha's Nithin Kamath and Groww are debating direct mutual fund offerings publicly. Kamath reiterated Zerodha's commitment ...

Amid Groww's recently launched MF Prime service, Nithin Kamath's comments on direct mutual funds have sparked a discussion ...

Zerodha co-founder Nithin Kamath has asked investors to understand the difference between ‘direct’ and ‘regular’ mutual fund ...

Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges with weekly injections and conservative doctor prescribing ...

The official clarification came in response to criticism from Zerodha’s Founder and CEO, Nithin Kamath, who took a swipe at ...

Generic GLP-1 weight-loss drugs have become significantly more affordable in India, but adoption remains slower than expected. Zerodha co-founder Nithin Kamath believes the issue isn't cost but ...

Nithin Kamath emphasizes Zerodha's dedication to providing free direct mutual funds, built on the principle of consistent ...

Nithin Kamath of Zerodha argues that effective investing is about adhering to basic principles like disciplined asset ...

The Zerodha founder said he had assumed such scams were largely a thing of the past, only to discover that pyramid schemes continue to proliferate across India.

In a post on X, Kamath wrote that he is amazed as to why GLP-1 sales haven't been able to pick up despite so many benefits.